Eden vs Enhance MD
Two GLP-1 providers, one scoreboard. We put Eden and Enhance MD head-to-head on the published Brief Score — the same six factors, scored the same way.
Eden
FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.
The verdict
Eden takes this head-to-head.
Eden scores 91 to 85 on our six-factor Brief Score — Eden now advertises compounded semaglutide and tirzepatide at recurring monthly prices without a separate membership fee; its FDA warning history remains relevant.
That doesn't make Enhance MD a bad call — it's best for readers who want to see the whole price ladder before they commit and value dose-flat billing plus routine lab work — and who don't need brand-name or oral options. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | Eden | Enhance MD |
|---|---|---|
| Brief Score | 91/100 (A−) | 85/100 (B) |
| Semaglutide | $99/mo No separate membership fee advertised. Same recurring rate; no long-term contract advertised. Full price details$99/month for compounded semaglutide on the current GLP-1 program; no separate membership fee or long-term contract advertised | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay |
| Tirzepatide | $129/mo No separate membership fee advertised. Same recurring rate; no long-term contract advertised. Full price details$129/month for compounded tirzepatide on the current GLP-1 program; no separate membership fee or long-term contract advertised | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Yes | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Fallingprice falling | Stableprice stable |
Eden: Current GLP-1 pages show $99/$129 each month, replacing the former separate-membership structure; confirm your selected program.
Enhance MD: The ladder is fully published, but its rungs are prepay blocks: $212 and $280 are the 12-MONTH rates, while month-to-month is $249 and $329 — and every plan bills every 4 weeks, so a "monthly" plan is 13 charges a year. The $112 is $212 less a dated SUMMER50 coupon, not an entry rate.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.